Refreshing results…
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence
UploadIFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma
UploadAn ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer
Download from www.nature.comNeoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma
UploadCOVID-19 vaccination: the VOICE for patients with cancer
UploadLearning from clinical trials of neoadjuvant checkpoint blockade
Download from www.nature.comLower risk of severe checkpoint inhibitor toxicity in more advanced disease
UploadMissing publications? Search for publications with a matching author name.